Precipitating antigens involved in protection against Aujeszkys disease after natural infection and after immunisation with inactivated vaccine Pigs, herpes hominis virus
Dalsgaard, K.
Current topics in veterinary medicine and animal Science 7(17): 107-115
1982
Accession: 016722653
PDF emailed within 1 workday: $29.90
Related References
Vannier, P.; Tillon J P.; Toma, B.; Delagneau J F.; Loquerie, R.; Prunet, P. 1976: Protection of pigs against the aujeszkys disease by a new oily inactivated vaccine practical consequences Annales de Zootechnie 25(3): 452Vannier, P. 1982: Efficiency of an inactivated virus vaccine against Aujeszkys disease for fattening pigs with or without passive immunity Current topics in veterinary medicine and animal Science 7(17): 181-190
Mcferran, J.; Mccracken, R.1; Dow, C. 1982: Comparative studies with inactivated and attenuated vaccines for protection of fattening pigs Aujeszkys disease virus Current topics in veterinary medicine and animal Science 7(17): 163-170
Hook, L.M.; Cairns, T.M.; Awasthi, S.; Brooks, B.D.; Ditto, N.T.; Eisenberg, R.J.; Cohen, G.H.; Friedman, H.M. 2018: Vaccine-induced antibodies to herpes simplex virus glycoprotein D epitopes involved in virus entry and cell-to-cell spread correlate with protection against genital disease in guinea pigs Plos Pathogens 14(5): E1007095
Bernstein, D.I.; Morello, C.S.; Cardin, R.D.; Bravo, F.J.; Kraynyak, K.A.; Spector, D.H. 2020: A vaccine containing highly purified virus particles in adjuvant provides high level protection against genital infection and disease in guinea pigs challenged intravaginally with homologous and heterologous strains of herpes simplex virus type 2 Vaccine 38(1): 79-89
Berbinschi, C. 1974: Romanian vaccine with inactivated virus used for the control of Aujeszkys disease Cahiers de medecine veterinaire: 43 (5, special issue) 324-329
Toma, B.D.lagneau, J.; Loquerie, R.P.unet, P. 1975: Study of a new inactivated and adjuvant virus vaccine against Aujeszkys disease Bulletin 4 223-237
Boursnell, M.E.; Entwisle, C.; Blakeley, D.; Roberts, C.; Duncan, I.A.; Chisholm, S.E.; Martin, G.M.; Jennings, R.; Ni Challanaín, D.; Sobek, I.; Inglis, S.C.; McLean, C.S. 1997: A genetically inactivated herpes simplex virus type 2 (HSV-2) vaccine provides effective protection against primary and recurrent HSV-2 disease Journal of Infectious Diseases 175(1): 16-25
Nedyalkov, S.; Ribarov, B.; Stoichev, S. 1968: Experiments to produce an inactivated vaccine against aujeszkys disease ii testing the duration of immunity and the validity for use of inactivated adsorbate vaccine sheep Veterinarno Meditsinski Nauki 5(4): 63-68
Wittmann, G.H.hn, U.O.linger, V.S.raub, O.; Weiland, F. 1983: Vaccination of cattle with an inactivated Aujeszkys disease virus (ADV) vaccine. II. Evaluation of immunity Tierarztliche Umschau 38(9): 583-585
Scriba, M. 1978: Protection of guinea pigs against primary and recurrent genital herpes infections by immunization with live heterologous or homologous Herpes simplex virus: implications for a herpes virus vaccine Medical Microbiology and Immunology 166(1-4): 63-69
Cunha, E.M.S.; Peixoto, Z.M.P.; Kotait, I.; Bersano, J.G.; Ishizuka, M.M.; Baccaro, M.R. 1998: Efficacy of an inactivated Aujeszky's disease virus vaccine: experimental infection of pigs Brazilian Journal of Veterinary Research and Animal Science 35(1-6): 188-194
Van Rooij, E.M.A.; de Bruin, M.G.M.; de Visser, Y.E.; Middel, W.G.J.; Boersma, W.J.A.; Bianchi, A.T.J. 2004: Vaccine-induced T cell-mediated immunity plays a critical role in early protection against pseudorabies virus (suid herpes virus type 1) infection in pigs Veterinary Immunology and Immunopathology 99(1-2): 113-125
Liu, W.; Li, X.; Zhang, H.; Hao, G.; Shang, X.; Wang, H.; Chen, H.; Qian, P. 2022: Evaluation of Immunoreactivity and Protection Efficacy of Seneca Valley Virus Inactivated Vaccine in Finishing Pigs Based on Screening of Inactivated Agents and Adjuvants Vaccines 10(4)
Scriba, M. 1978: Animal studies on the efficacy of an inactivated herpes simplex virus vaccine against recurrent herpes infection Infection 6(3): 137-139
Awasthi, S.; Balliet, J.W.; Flynn, J.A.; Lubinski, J.M.; Shaw, C.E.; DiStefano, D.J.; Cai, M.; Brown, M.; Smith, J.F.; Kowalski, R.; Swoyer, R.; Galli, J.; Copeland, V.; Rios, S.; Davidson, R.C.; Salnikova, M.; Kingsley, S.; Bryan, J.; Casimiro, D.R.; Friedman, H.M. 2014: Protection provided by a herpes simplex virus 2 (HSV-2) glycoprotein C and D subunit antigen vaccine against genital HSV-2 infection in HSV-1-seropositive guinea pigs Journal of Virology 88(4): 2000-2010
Nedjalkov, S.; Stoitschev, S.; Ribarov, B.; Stoilova, N. 1968: Attempts produce a vaccine against aujeszkys disease from inactivated virus 1st communication chicken rabbit sheep pig crystal violet saponin beta propriolactone Archiv fuer Experimentelle Veterinaermedizin 22(3): 449-507
Zuffa, A. 1986: Induction of biological protection in pigs against infection with Aujeszky disease virus by vaccination with large doses of live or inactivated vaccines Veterinarni Medicina 31(2): 83-94
Oirschot, J.-Van; Leeuw, P.-De1; Zaane, D.V.no 1982: Early protection after vaccination against Aujeszkys disease Pigs, modified live virus Current topics in veterinary medicine and animal Science 7(17): 171-179
Johnson, P.R.; Feldman, S.; Thompson, J.M.; Mahoney, J.D.; Wright, P.F. 1986: Immunity to influenza a virus infection in young children: a comparison of natural infection, live cold-adapted vaccine, and inactivated vaccine Journal of Infectious Diseases 154(1): 121-127